Sendai, Japan

Yoshimi Yano

This inventor holds 1 USPTO granted patent. Top assignee: Pola Chemical Industries, Inc.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshimi Yano. Retrieved from https://idiyas.com/inventor/yoshimi-yano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Yoshimi Yano

Introduction

Yoshimi Yano is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of medical science, particularly in the differentiation of human peripheral blood granulocytes. His work is crucial for advancing patient care in serious infectious diseases and inflammation.

Latest Patents

Yano holds a patent for a method that differentiates human peripheral blood granulocytes. This method involves cultivating granulocytes in the presence of an interferon and applying an immune complex along with a chemiluminescent substance. The chemiluminescent amounts induced are then measured. This innovative approach aids in screening patients suffering from serious infectious diseases and monitoring their curative effects. He has 1 patent to his name.

Career Highlights

Yoshimi Yano is associated with Pola Chemical Industries, Inc., where he continues to contribute to research and development in his field. His expertise and innovative methods have positioned him as a valuable asset in the medical research community.

Collaborations

Yano has worked alongside esteemed colleagues such as Toshiro Majima and Ryoichi Nagatomi. Their collaborative efforts have further enhanced the impact of their research and innovations.

Conclusion

Yoshimi Yano's contributions to the differentiation of human peripheral blood granulocytes represent a significant advancement in medical science. His innovative methods are essential for improving patient outcomes in serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…